🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
This study aims to evaluate the efficacy, safety and tolerability, pharmaco...
Status
Terminated
Location
Thrive Health - Beverly Hills
Start Date
2024-03-27
Trial ID
NCT06307613
Treatments Being Tested
This study is part of the ADAPT Forward platform study (NCT07294170). ADAPT...
Status
Recruiting
Location
Visionary Investigators Network
Start Date
2026-07-10
Trial ID
NCT07673627
Treatments Being Tested
This is a phase 2 study to assess the ability of adalimumab as compared to ...
Status
Recruiting
Location
Cedars Sinai Medical Center
Start Date
2026-08-17
Trial ID
NCT06996652
Treatments Being Tested
Sirukumab is a fully human anti-interleukin-6 (IL-6) immunoglobulin G1-kapp...
Status
Terminated
Location
GSK Investigational Site
Start Date
2015-10-16
Trial ID
NCT02531633
Treatments Being Tested
This study \[contRAst 1 (201790: NCT03980483)\] is a phase 3, randomized, m...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-05-16
Trial ID
NCT03980483
Treatments Being Tested
Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham: The Kirklin Clinic
Start Date
2023-07-06
Trial ID
NCT05852938
This study will investigate the efficacy, safety and tolerability of a new ...
Status
Terminated
Location
Teva Investigational Site 10192
Start Date
2012-03
Trial ID
NCT01578785
Treatments Being Tested
The primary objective of this study is to assess the safety and efficacy of...
Status
Completed
Location
Burke Pharmaceutical Research /ID# 211671
Start Date
2019-06-03
Trial ID
NCT03926169
Treatments Being Tested
This study will assess whether switching participants who have benefitted f...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-26
Trial ID
NCT04718389